Does sertraline cause tinnitus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Sertraline and Tinnitus: Understanding the Paradox

While sertraline can rarely cause tinnitus as a side effect, the evidence shows it is more commonly effective in treating severe, bothersome tinnitus—particularly when depression or anxiety coexist—making the relationship between sertraline and tinnitus complex and context-dependent.

The Evidence on Sertraline Causing Tinnitus

FDA-Documented Side Effect Profile

The FDA label for sertraline does not list tinnitus among the common adverse events (those occurring in ≥2% of patients with incidence greater than placebo) across major clinical trials 1. This indicates tinnitus is not a frequent side effect in controlled settings.

Rare Case Reports

Tinnitus as a side effect of sertraline is documented but uncommon:

  • A case report describes bilateral tinnitus developing after several weeks of sertraline 50 mg, which completely resolved after discontinuation 2
  • The mechanism may involve serotonin receptor distribution within the auditory system, with potential "priming effects" from concurrent medications like aspirin 2
  • Tinnitus has been reported with sertraline withdrawal, not just during active treatment 3

Real-World Adverse Event Data

Analysis of the FDA Adverse Event Reporting System (FAERS) database from 2012-2023 identified 29,460 cases of drug-related tinnitus across all medications. Sertraline was not among the top 25 drugs most strongly associated with tinnitus—duloxetine, ciprofloxacin, and adalimumab showed the strongest associations 4.

The Evidence on Sertraline Treating Tinnitus

Clinical Trial Evidence

The highest quality evidence demonstrates sertraline's efficacy in treating severe tinnitus:

  • A randomized, double-blind, placebo-controlled trial (n=76) showed sertraline 50 mg/day was significantly more effective than placebo in reducing tinnitus severity (p=0.024) and perceived loudness (p=0.014) over 16 weeks 5
  • Improvements correlated with reductions in depressive (r=0.42-0.46) and anxiety symptoms (r=0.34-0.42) 5
  • A 2017 randomized trial comparing melatonin and sertraline found both effective, though melatonin showed slightly better outcomes 6

Guideline Recommendations

The 2014 AAO-HNS Clinical Practice Guideline explicitly recommends against routine use of antidepressants for primary tinnitus treatment 7. However, this recommendation has important nuances:

  • The guideline notes "potential for some medications (e.g., antidepressants) to worsen tinnitus" but acknowledges "these therapies appear to be beneficial in some studies" 7
  • The recommendation against routine use is based on methodological concerns in trials and the need to avoid unproven therapy in all patients 7
  • Cognitive-behavioral therapy (CBT) receives a strong recommendation for persistent, bothersome tinnitus 7

The 2025 VA/DOD guideline update emphasizes evidence-based education, self-management, and outcome monitoring but highlights significant gaps in knowledge requiring further study 8.

Clinical Decision-Making Algorithm

When Sertraline May Cause Tinnitus (Rare):

  • New-onset bilateral tinnitus developing within weeks of starting sertraline
  • No other identifiable cause on medical workup
  • Resolution upon discontinuation
  • Action: Discontinue sertraline and consider alternative antidepressant

When Sertraline May Treat Tinnitus (More Common):

  • Severe, persistent, bothersome tinnitus
  • Coexisting depression or anxiety (most important predictor of benefit)
  • Failed conservative measures (sound therapy, hearing aids if indicated)
  • Action: Consider sertraline 50 mg/day after discussing risks/benefits

Key Caveats:

  • The 17% early dropout rate in trials suggests tolerability issues in the first 2 weeks 5
  • Patients with concurrent aspirin or NSAID use may have altered risk profiles 2
  • CBT should be the first-line intervention for persistent bothersome tinnitus per guidelines 7
  • Sound therapy and hearing amplification (if hearing loss present) are evidence-based non-pharmacologic options 7

Bottom Line for Clinical Practice

The concern that "sertraline causes tinnitus" is valid but overstated. While rare cases exist 2, sertraline is not among the medications most strongly associated with tinnitus in post-marketing surveillance 4. Conversely, high-quality RCT evidence supports sertraline's efficacy in treating severe refractory tinnitus, particularly when depression or anxiety coexist 5.

If a patient develops new tinnitus on sertraline, discontinue the medication. If a patient has severe tinnitus with depression/anxiety that hasn't responded to CBT and sound therapy, sertraline 50 mg/day is a reasonable evidence-based option, with close monitoring during the first 2 weeks for tolerability 5.

References

Research

Antidepressant therapy in tinnitus.

Hearing research, 2007

Research

Analysis of Drug-Related Tinnitus Based on the FDA Adverse Event Reporting System Database.

British journal of hospital medicine (London, England : 2005), 2024

Guideline

clinical practice guideline: tinnitus executive summary.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.